Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
40.37
+0.39 (0.97%)
Feb 5, 2025, 12:42 PM EST - Market open
Xenon Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -213.39 | -182.39 | -125.37 | -78.88 | -28.84 | -41.6 | Upgrade
|
| Depreciation & Amortization | 2.78 | 3.54 | 1.62 | 0.91 | 0.64 | 0.43 | Upgrade
|
| Other Amortization | - | - | - | - | 0.22 | 0.53 | Upgrade
|
| Loss (Gain) From Sale of Investments | 4.84 | -3.55 | 2.93 | 0.72 | -0 | -0.08 | Upgrade
|
| Stock-Based Compensation | 46.3 | 32.37 | 20.38 | 10.02 | 5.68 | 2.92 | Upgrade
|
| Other Operating Activities | -0.16 | -0.93 | 2.69 | 0.39 | 0.27 | -0.44 | Upgrade
|
| Change in Accounts Receivable | -0.36 | 0.13 | 1.76 | -0.46 | -1.03 | -0.65 | Upgrade
|
| Change in Accounts Payable | 4.65 | 3.93 | 8.06 | 2.97 | 2.02 | 4.54 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -3.64 | -26.81 | 30.45 | Upgrade
|
| Change in Other Net Operating Assets | -1.28 | 1.57 | -10.5 | -1.52 | -0.27 | -0.82 | Upgrade
|
| Operating Cash Flow | -156.62 | -145.33 | -98.43 | -69.5 | -48.12 | -4.71 | Upgrade
|
| Capital Expenditures | -2.37 | -5.62 | -2.89 | -2.05 | -2.64 | -1.24 | Upgrade
|
| Investment in Securities | -176.71 | -111.55 | -293.11 | -244.72 | -14.19 | -64.97 | Upgrade
|
| Investing Cash Flow | -179.08 | -117.17 | -296 | -246.77 | -16.82 | -66.21 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -16.74 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | -16.74 | - | Upgrade
|
| Issuance of Common Stock | 324.01 | 353.52 | 278.47 | 447.54 | 102.54 | 27.52 | Upgrade
|
| Financing Cash Flow | 324.01 | 353.52 | 278.47 | 447.54 | 85.8 | 27.52 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.27 | 0.38 | -2.48 | -0.59 | -0.59 | 0.41 | Upgrade
|
| Net Cash Flow | -11.95 | 91.4 | -118.45 | 130.68 | 20.25 | -43 | Upgrade
|
| Free Cash Flow | -158.99 | -150.94 | -101.32 | -71.55 | -50.76 | -5.95 | Upgrade
|
| Free Cash Flow Margin | - | - | -1074.03% | -388.09% | -157.81% | -87.19% | Upgrade
|
| Free Cash Flow Per Share | -2.10 | -2.26 | -1.67 | -1.64 | -1.41 | -0.20 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.34 | 0.92 | Upgrade
|
| Levered Free Cash Flow | -109.47 | -98.4 | -54.08 | -43.76 | -41.29 | 7.96 | Upgrade
|
| Unlevered Free Cash Flow | -109.47 | -98.4 | -54.08 | -43.76 | -41.2 | 8.33 | Upgrade
|
| Change in Net Working Capital | -3.52 | -5.09 | -7.53 | 3.26 | 25.32 | -32.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.